{"desc": "Ratio is a privately held discovery-stage biotechnology company that utilizes a suite of technologies licensed from Cornell University to develop best-in-class targeted radiotherapeutics for the treatment of metastatic cancers.", "file_name": "cvvbMOTtKb-cancer-cells-on-a-blue-background-jpg_2048x.jpg", "size": [1206, 566], "layout": [{"type": "static-text", "position": [0, 0, 1206, 566], "text": ""}, {"type": "background", "position": [0, 0, 1206, 566], "text": ""}, {"type": "static-text", "position": [96, 197, 984, 49], "text": "Developing best-in-class radiopharmaceuticals"}, {"type": "static-text", "position": [96, 245, 396, 49], "text": "for cancer patients"}, {"type": "static-text", "position": [96, 312, 813, 80], "text": "A discovery through early clinical phase pharmaceutical company, Ratio Therapeutics employs a suite of innovative technologies to develop best-in-class targeted radiotherapeutics for the treatment of cancers"}, {"type": "image", "position": [96, 198, 1025, 198], "text": ""}]}